Cyrus M. Khan, MD, discussed recent advancements in CLL treatment, particularly the shift to nonchemotherapy options and the ...
Eli Lilly has announced that the company will present data from studies of Jaypirca (pirtobrutinib) at the 66th American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback